FDA Inspection 1102991 — Tower Pharmacy and Compounding

Tower Pharmacy and Compounding — FEI 3010504654

The FDA completed an inspection of Tower Pharmacy and Compounding on September 19, 2019 in Mission Viejo, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 19, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mission Viejo, CA (United States)

Citations

IDCFRDescription
18939FDCA 501(a)(2)(A)Highly potent drugs, prevention of cross-contamination
21377FDCA 501(a)(2)(A)Use of non-pharmaceutical grade components